• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内微生物群与鼻咽癌的全身免疫炎症状态有关。

Intratumoral microbiota associates with systemic immune inflammation state in nasopharyngeal carcinoma.

机构信息

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei 430071, China.

Department of Laboratory Medicine, The First People's Hospital of Tianmen City, Tianmen, Hubei 431700, China.

出版信息

Int Immunopharmacol. 2024 Nov 15;141:112984. doi: 10.1016/j.intimp.2024.112984. Epub 2024 Aug 21.

DOI:10.1016/j.intimp.2024.112984
PMID:39173404
Abstract

BACKGROUND

The nasopharynx serves as a crucial niche for the microbiome of the upper respiratory tract. However, the association between the intratumoral microbiota and host systemic inflammation and immune status in nasopharyngeal carcinoma (NPC) remain uncertain.

METHODS

We performed 5R 16S rDNA sequencing on NPC tissue samples, followed by diversity analysis, LEfSe differential analysis, and KEGG functional prediction. The analyses were based on indices such as AISI, SIRI, PAR, PLR, and NAR. Correlation analyses between microbes and these indices were performed to identify microbes associated with inflammation and immune status. Additionally, regression analysis based on tumor TNM stage was performed to identify key microbes linked to tumor progression. The head and neck squamous cell carcinoma (HNSC) transcriptome and the paired HNSC microbiome data from TCGA were utilized to validate the analyses.

RESULTS

The Proteobacteria, Actinobacteria, Firmicutes, and Bacteroidetes were the most enriched phyla in NPC tissues. Microbes within these phyla demonstrated high sensitivity to changes in host systemic inflammation and immune status. Proteobacteria and Firmicutes showed significant differences between inflammation groups. Actinobacteria varied specifically with platelet-related inflammatory indices, and Bacteroidetes genera exhibited significant differences between NAR groups. Corynebacterium and Brevundimonas significantly impacted the T stage of tumors, with a high load of Corynebacterium within tumors associated with a better prognosis CONCLUSION: Our analysis indicates that Proteobacteria play a crucial role in the inflammatory state of NPC, while Bacteroidetes are more sensitive to the tumor immune status.

摘要

背景

鼻咽部是上呼吸道微生物组的重要栖息地。然而,鼻咽癌(NPC)肿瘤内微生物群与宿主全身炎症和免疫状态之间的关系尚不清楚。

方法

我们对 NPC 组织样本进行了 5R16S rDNA 测序,随后进行了多样性分析、LEfSe 差异分析和 KEGG 功能预测。分析基于 AISI、SIRI、PAR、PLR 和 NAR 等指标。对微生物与这些指标之间的相关性进行了分析,以确定与炎症和免疫状态相关的微生物。此外,还基于肿瘤 TNM 分期进行了回归分析,以确定与肿瘤进展相关的关键微生物。我们利用 TCGA 中的头颈部鳞状细胞癌(HNSC)转录组和配对 HNSC 微生物组数据来验证分析。

结果

在 NPC 组织中,变形菌门、放线菌门、厚壁菌门和拟杆菌门是最丰富的门。这些门内的微生物对宿主全身炎症和免疫状态的变化具有高度敏感性。变形菌门和厚壁菌门在炎症组之间存在显著差异。放线菌门与血小板相关炎症指标特异性变化,拟杆菌门属在 NAR 组之间存在显著差异。棒状杆菌属和短小芽孢杆菌属显著影响肿瘤的 T 分期,肿瘤内棒状杆菌属负荷较高与预后较好相关。

结论

我们的分析表明,变形菌门在 NPC 的炎症状态中起着关键作用,而拟杆菌门对肿瘤免疫状态更为敏感。

相似文献

1
Intratumoral microbiota associates with systemic immune inflammation state in nasopharyngeal carcinoma.肿瘤内微生物群与鼻咽癌的全身免疫炎症状态有关。
Int Immunopharmacol. 2024 Nov 15;141:112984. doi: 10.1016/j.intimp.2024.112984. Epub 2024 Aug 21.
2
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.中国 2 家医院的鼻咽癌患者肿瘤内微生物群与预后的关联。
JAMA Oncol. 2022 Sep 1;8(9):1301-1309. doi: 10.1001/jamaoncol.2022.2810.
3
Characterization of the nasopharynx microbiota in patients with nasopharyngeal carcinoma vs. healthy controls.鼻咽癌患者与健康对照者鼻咽微生物群特征。
Braz J Microbiol. 2021 Dec;52(4):1873-1880. doi: 10.1007/s42770-021-00594-0. Epub 2021 Sep 7.
4
Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.基于免疫炎症的指数的开发和验证,用于预测鼻咽癌患者的临床结局。
J Cell Mol Med. 2020 Aug;24(15):8326-8349. doi: 10.1111/jcmm.15097. Epub 2020 Jun 30.
5
The role of microbiota in nasopharyngeal cancer: Where do we stand?肠道微生物群在鼻咽癌中的作用:我们处于什么位置?
Oral Oncol. 2024 Nov;158:106982. doi: 10.1016/j.oraloncology.2024.106982. Epub 2024 Aug 16.
6
Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.肿瘤内微生物组随肿瘤分期变化,并影响口腔鳞状细胞癌的免疫特征。
Microbiol Spectr. 2023 Aug 17;11(4):e0459622. doi: 10.1128/spectrum.04596-22. Epub 2023 Jul 6.
7
Analysis of 16S rRNA Gene Sequence of Nasopharyngeal Exudate Reveals Changes in Key Microbial Communities Associated with Aging.鼻咽分泌物 16S rRNA 基因序列分析揭示与衰老相关的关键微生物群落变化。
Int J Mol Sci. 2023 Feb 18;24(4):4127. doi: 10.3390/ijms24044127.
8
The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.肝细胞癌的肿瘤内细菌分类群特征。
Microbiol Spectr. 2022 Oct 26;10(5):e0098322. doi: 10.1128/spectrum.00983-22. Epub 2022 Sep 29.
9
Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy.接受放化疗的鼻咽癌患者唾液微生物群的变化
Arch Oral Biol. 2014 Feb;59(2):176-86. doi: 10.1016/j.archoralbio.2013.10.011. Epub 2013 Nov 4.
10
Tumor-associated characteristics and immune dysregulation in nasopharyngeal carcinoma under the regulation of m7G-related tumor microenvironment cells.肿瘤微环境细胞中 m7G 相关修饰调控的鼻咽癌相关特征和免疫失调。
World J Surg Oncol. 2024 Jun 25;22(1):166. doi: 10.1186/s12957-024-03441-2.

引用本文的文献

1
The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy.肿瘤内微生物群在结直肠癌免疫治疗中的作用与挑战
Front Pharmacol. 2025 Aug 7;16:1634703. doi: 10.3389/fphar.2025.1634703. eCollection 2025.
2
Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy.利用肿瘤内微生物群:免疫微环境与免疫治疗的新视野
J Transl Med. 2025 Aug 12;23(1):897. doi: 10.1186/s12967-025-06916-2.
3
The Prognostic Significance of the CALLY Index in Ampullary Carcinoma: An Inflammation-Nutrition Retrospective Analysis.
CALLY指数在壶腹癌中的预后意义:一项炎症-营养回顾性分析
J Inflamm Res. 2025 Jan 16;18:621-635. doi: 10.2147/JIR.S495815. eCollection 2025.